Authors
Loading...
Genome-wide screen identifies USP17L13 as a negative regulator of innate immunity, enhancing influenza virus replication in human lung cells, suggesting new therapeutic targets.
ZHANG et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: